{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:10:57Z","timestamp":1790143857840,"version":"4.0.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    Feline calicivirus (FCV) is a significant pathogen responsible for upper respiratory tract disease and oral ulceration in felids. Genetic and antigenic variation in circulating FCV strains limits the utility of current diagnostic assays, and no validated genotype II-specific antibodies exist for rapid test development. In this study, we targeted the C, D, E, and partial F regions of the major capsid protein VP1 (termed VP1-CDEF'). The recombinant VP1-CDEF' protein was expressed in a prokaryotic system and used to immunize SPF chickens. A chicken-derived phage display single-chain variable fragment (scFv) library was successfully constructed, with a capacity of 5.25\u202f\u00d7\u202f10\n                    <jats:sup>7<\/jats:sup>\n                    transformants and an insert-positive rate of approximately 80%. After three rounds of solid-phase biopanning, the phage recovery ratio increased from 3.6\u202f\u00d7\u202f10\n                    <jats:sup>\u22126<\/jats:sup>\n                    to 6.4\u202f\u00d7\u202f10\n                    <jats:sup>\u22123<\/jats:sup>\n                    , representing an enrichment factor of 1,777.78-fold. Phage-ELISA screening of 184 randomly selected clones yielded 25 positive clones, and sequence analysis identified five scFv antibodies with unique amino acid sequences, designated 1A2, 2B2, 2C1, 2E1, and 2G5. The scFv genes were constructed into scFv-Fc fusion proteins and expressed in Expi293F cells. Western blot analysis demonstrated that all five scFv-Fc fusion proteins specifically recognized the recombinant VP1-CDEF' protein and exhibited no cross-reactivity with feline parvovirus VP2 protein. In indirect immunofluorescence assay (IFA)-based binding assays, however, only 2B2-Fc, 2E1-Fc, and 2G5-Fc were capable of binding genotype II FCV strain LZ2023 in infected F81 cells. Virion capture ELISA using purified intact FCV particles confirmed that 2B2-Fc, 2E1-Fc, and 2G5-Fc bind to surface-accessible epitopes on native virions, whereas 1A2-Fc and 2C1-Fc showed no detectable binding. Biolayer interferometry (BLI) analysis showed that 2B2-Fc and 2E1-Fc exhibited the highest binding affinities, with equilibrium dissociation constant (KD) values of 0.046\u202fnmol\/L and 0.032\u202fnmol\/L, respectively, whereas 2G5-Fc displayed moderate affinity (KD\u202f=\u202f65.44\u202fnmol\/L). 1A2-Fc and 2C1-Fc showed relatively weak binding (KD\u202f&amp;gt;\u202f450\u202fnmol\/L). This study reports the generation of chicken-derived scFv antibodies targeting the FCV VP1-CDEF' region. The high-affinity clones 2B2 and 2E1 are promising candidates for rapid diagnostic test development and warrant further evaluation. However, further validation of their diagnostic utility will require clinical sample studies and the development of colloidal gold strips based on these scFv.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2026.1896418","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:50:12Z","timestamp":1790142612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["High-affinity chicken scFv antibodies recognize recombinant VP1-CDEF' protein and native virions of feline calicivirus genotype II strain LZ2023"],"prefix":"10.3389","volume":"17","author":[{"given":"Yanquan","family":"Wei","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Gansu Agricultural University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Gansu Agricultural University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Han","sequence":"additional","affiliation":[{"name":"Sichuan Purity Pharmaceutical Co., Ltd.","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huitian","family":"Gou","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Gansu Agricultural University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqi","family":"Lian","sequence":"additional","affiliation":[{"name":"School of Biological and Food Engineering, Anyang Institute of Technology","place":["Anyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Sun","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Ji","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Gansu Agricultural University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"980250","DOI":"10.1155\/2012\/980250","article-title":"scFv antibody: principles and clinical application","author":"Ahmad","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.3390\/ijms26136380","article-title":"Latest findings in immunoglobulin Y technologies and applications","volume":"26","author":"Capota","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-018-0852-1","article-title":"Calicivirus VP2 forms a portal-like assembly following receptor engagement","volume":"565","author":"Conley","year":"2019","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13567-020-00785-x","article-title":"Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies","volume":"51","author":"Cubillos-Zapata","year":"2020","journal-title":"Vet. Res."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-1-4939-6412-3_16","article-title":"Optimized generation of high-affinity, high-specificity single-chain Fv antibodies from multi-antigen immunized chickens","volume":"1485","author":"Finlay","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1365-2222.2005.02307.x","article-title":"Exploiting the avian immunoglobulin system to simplify the generation of recombinant antibodies to allergenic proteins","volume":"35","author":"Finlay","year":"2005","journal-title":"Clin. Exp. Allergy"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13567-020-00832-7","article-title":"Canine parvovirus is diagnosed and neutralized by chicken IgY-scFv generated against the virus capsid protein","volume":"51","author":"Ge","year":"2020","journal-title":"Vet. Res."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1804038","DOI":"10.1155\/2024\/1804038","article-title":"The potential of single-chain variable fragment antibody: role in future therapeutic and diagnostic biologics","volume":"2024","author":"Gezehagn Kussia","year":"2024","journal-title":"J. Immunol. Res."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/microorganisms12061148","article-title":"Construction and validation of chicken immune scFv antibody library against Helicobacter pylori","volume":"12","author":"Gong","year":"2024","journal-title":"Microorganisms"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3390\/v14050937","article-title":"Calicivirus infection in cats","volume":"14","author":"Hofmann-Lehmann","year":"2022","journal-title":"Viruses"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e70540","DOI":"10.1002\/vms3.70540","article-title":"Suspected feline calicivirus infection triggering ulcerative oral and skin lesions in cats following routine ovariohysterectomy: a postoperative risk assessment","volume":"11","author":"Karakaya-Bilen","year":"2025","journal-title":"Vet. Med. Sci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jviromet.2007.06.010","article-title":"Chicken single-chain variable fragments against the SARS-CoV spike protein","volume":"146","author":"Lee","year":"2007","journal-title":"J. Virol. Methods"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12917-024-03914-2","article-title":"The CDE region of feline calicivirus VP1 protein is a potential candidate subunit vaccine","volume":"20","author":"Li","year":"2024","journal-title":"BMC Vet. Res."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"105323","DOI":"10.1016\/j.meegid.2022.105323","article-title":"Genetic and phylogenetic analysis of capsid gene of feline calicivirus in Nanjing, China","volume":"103","author":"Liang","year":"2022","journal-title":"Infect. Genet. Evol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.virusres.2012.05.026","article-title":"Mapping of antigenic determinants on a SAT2 foot-and-mouth disease virus using chicken single-chain antibody fragments","volume":"167","author":"Opperman","year":"2012","journal-title":"Virus Res."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2249.2001.01515.x","article-title":"Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the fc region of human IgG1","volume":"125","author":"Ray","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00705-002-0931-2","article-title":"Generation of chicken single chain antibody variable fragments (scFv) that differentiate and neutralize infectious bursal disease virus (IBDV)","volume":"148","author":"Sapats","year":"2003","journal-title":"Arch. Virol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6750-4-6","article-title":"A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes","volume":"4","author":"van Wyngaardt","year":"2004","journal-title":"BMC Biotechnol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/ani15040494","article-title":"Epidemiology and molecular characterization of feline calicivirus in Beijing, China","volume":"15","author":"Wang","year":"2025","journal-title":"Animals (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1388420","DOI":"10.3389\/fmicb.2024.1388420","article-title":"Update on feline calicivirus: viral evolution, pathogenesis, epidemiology, prevention and control","volume":"15","author":"Wei","year":"2024","journal-title":"Front. Microbiol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.4049\/jimmunol.157.3.1156","article-title":"Chicken monoclonal antibody isolated by a phage display system","volume":"157","author":"Yamanaka","year":"1996","journal-title":"J. Immunol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/vaccines12111205","article-title":"Screening and immune efficacy evaluation of antigens with protection against feline Calicivirus","volume":"12","author":"Yang","year":"2024","journal-title":"Vaccines (Basel)"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1896418\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:50:13Z","timestamp":1790142613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1896418\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":22,"alternative-id":["10.3389\/fmicb.2026.1896418"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1896418","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1896418"}}